ETROLIZUMAB AS INDUCTION AND MAINTENANCE THERAPY IN PATIENTS WITH ULCERATIVE COLITIS PREVIOUSLY EXPOSED TO ANTI-TUMOR NECROSIS FACTOR AGENT: THE RANDOMIZED, PHASE 3 HICKORY TRIAL

Laurent Peyrin-Biroulet  1     Ailsa L Hart  2     Peter Bossuyt  3     Millie Long  4     Matthieu Allez  5     Pascal Juillerat  6     Alessandro Armuzzi     Edward V Loftus Jr     Elham Ostad-Saffari     Astrid Scalori     Young Oh     Swati Tole     Akiko Chai     Jennifer Pulley     Stuart Lacey     William Sandborn    
1 Université de Lorraineo-Gastroenterology,Nancy,France
2 St Mark's Academic Institute,London,United Kingdom
3 Imelda GI Clinical Research Center, Imelda General Hospital,Bonheiden,Belgium
4 University of North Carolina,Chapel Hill,United States
5 Hôpital Saint-Louis, APHP, Université de Paris,Paris,France
6 Inselspital, Bern University Hosp

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing